Table 1.
Disease recurrent stage, surgery, post-surgery adjuvant treatment and outcome
| Sl. no. | Age/Sex | Recurrent stage (rT) | Surgery | Post-surgery adjuvant treatment | Outcome |
|---|---|---|---|---|---|
| 1 | 41/M | rT2 after 1 year of primary treatment | Endoscopic Nasopharyngectomy | CT | Post-surgery residual local disease |
| 2 | 35/M | rT1 after 1 year of primary treatment | Endoscopic Nasopharyngectomy | CT | Locoregionally disease recurred |
| 3 | 35/M | rT2 after 2 years of primary treatment | Endoscopic Nasopharyngectomy | CTRT | NED |
| 4 | 17/F | rT2 in less than 1 year of primary treatment | Endoscopic Nasopharyngectomy and RND | CT | Metastasis to liver |
| 5 | 43/F | rT2 after 1 year of primary treatment | Endoscopic Nasopharyngectomy | CT | Tumor recurred locally with intracranial extension |
| 6 | 45/M | rT2 after 2 years of primary treatment | Endoscopic Nasopharyngectomy | CTRT | Relapse neck node for which patient underwent RND but disease recurred locally |
| 7 | 45/M | rT2 in less than 1 years of primary treatment | Endoscopic Nasopharyngectomy and RND | CT | Tumor recurred locally but patient surviving till date on palliative ct |
| 8 | 36/M | rT1 after 1 year of primary treatment | Endoscopic Nasopharyngectomy | None | NED |
| 9 | 52/F | rT2 after 4 years of primary treatment | Endoscopic Nasopharyngectomy | CTRT | NED |
| 10* | 52/M | rT1 after 2 years of primary treatment | Endoscopic Nasopharyngectomy | None | NED |
M Male, F Female, CT Chemotherapy, CTRT Concurrent Chemo-Radiotherapy
*Patient underwent second endoscopic surgery for recurrent tumor confined to nasal cavity
NED = No evidence of disease